Genetic basis of psoriasis vulgaris and its pharmacogenetic potential

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.3, 2003-05, pp. : 297-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetic Techniques for Pharmacogenetic Analyses

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 231-237

Bentham Science Publishers

Access to resources Recommend Favorite

The pharmacogenetic basis of adverse drug reactions

By John C.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 83-84

Adis International

Access to resources Recommend Favorite

Hypokalemia: A Practical Approach to Diagnosis and its Genetic Basis

Current Medicinal Chemistry, Vol. 14, Iss. 14, 2007-06 ,pp. : 1551-1565

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 2, 2014-06 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

Calcipotriol/Betamethasone Dipropionate: A Review of its Use in the Treatment of Psoriasis Vulgaris of the Trunk, Limbs and Scalp

By McCormack Paul L.

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 709-730

Adis International

Access to resources Recommend Favorite